KNSA peer analysis
Kiniksa (KNSA) against its competitors: price, today's move, 1-year return and market value side by side.
KNSA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.78 | -4.79% | 51.81% | $615.29M |
| ANAB AnaptysBio | $47.02 | -2.61% | 28.93% | $1.44B |
| AVTX Avalo Therapeutics | $7.32 | 2.02% | -59.44% | – |
| DNTH Dianthus Therapeutics | $82.24 | -0.17% | 143.75% | – |
| IMVT Immunovant | $28.45 | -2.47% | 14.63% | $6.03B |
| NRIX Nurix Therapeutics | $25.70 | -4.09% | 101.13% | – |
| ORKA Oruka Therapeutics | $95.44 | -1.48% | 239.52% | – |
| PHAR Pharming Group | $12.13 | -1.06% | -9.55% | – |
| SYRE Spyre Therapeutics | $95.55 | -1.05% | 293.84% | – |
| KNSA Kiniksa | $91.50 | -0.80% | 145.37% | $7.25B |
- KNSA's peers: ACRS (Aclaris Therapeutics), ANAB (AnaptysBio), AVTX (Avalo Therapeutics), DNTH (Dianthus Therapeutics), IMVT (Immunovant), NRIX (Nurix Therapeutics), ORKA (Oruka Therapeutics), PHAR (Pharming Group).
Updated 2026-11-03 02:03 UTC